世界のハンター症候群治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hunter Syndrome Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4334
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ハンター症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素補充療法（ERT）、造血幹細胞移植（HSCT）、その他）、用途別市場規模（ライフサイエンス企業、研究所、病院）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ハンター症候群治療の市場動向
・企業の競争状況、市場シェア
・ハンター症候群治療の種類別市場規模と予測2016-2027（酵素補充療法（ERT）、造血幹細胞移植（HSCT）、その他）
・ハンター症候群治療の用途別市場規模と予測2016-2027（ライフサイエンス企業、研究所、病院）
・ハンター症候群治療の北米市場規模2016-2027（アメリカ、カナダ）
・ハンター症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ハンター症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ハンター症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ハンター症候群治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Takeda、GC Pharma.、JCR Pharmaceuticals Co Ltd.、RegenxBio Inc.、Sangamo Therapeutics, Inc.、ArmaGen Inc.、Inventiva S.A.、Denali Therapeutics Inc.、Bioasis Technologies Inc.、Esteve）
・結論

Hunter syndrome or Mucopolysaccharidosis type 2 is an inherited genetic disorder caused by malfunctioning or missing enzyme. Hunter syndrome affects several parts of the body and shows symptoms such as large round cheeks, enlarged tongue, full lips, and broad nose. As the disorder advances by age, individuals need more medical assistance. Hunter syndrome is a very rare kind of disorder which affects one in a million have a life expectancy of 10 – 20 years. Although there is no permanent cure for this disorder, some of the treatments such as enzyme replacement therapy (ERP) is conducted for reducing symptoms of Hunter syndrome.

Market Analysis and Insights: Global Hunter Syndrome Treatment Market
The global Hunter Syndrome Treatment market size is projected to reach US$ 1070 million by 2027, from US$ 772.6 million in 2020, at a CAGR of 4.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hunter Syndrome Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hunter Syndrome Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hunter Syndrome Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hunter Syndrome Treatment market.

Global Hunter Syndrome Treatment Scope and Market Size
Hunter Syndrome Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hunter Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Enzyme Replacement Therapy (ERT)
Hematopoietic Stem Cell Transplant (HSCT)
Others

Segment by Application
Life Science Companies
Research Institutes
Hospital

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Takeda
GC Pharma.
JCR Pharmaceuticals Co Ltd.
RegenxBio Inc.
Sangamo Therapeutics, Inc.
ArmaGen Inc.
Inventiva S.A.
Denali Therapeutics Inc.
Bioasis Technologies Inc.
Esteve

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hunter Syndrome Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Enzyme Replacement Therapy (ERT)
1.2.3 Hematopoietic Stem Cell Transplant (HSCT)
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hunter Syndrome Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Life Science Companies
1.3.3 Research Institutes
1.3.4 Hospital
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hunter Syndrome Treatment Market Perspective (2016-2027)
2.2 Hunter Syndrome Treatment Growth Trends by Regions
2.2.1 Hunter Syndrome Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hunter Syndrome Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hunter Syndrome Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hunter Syndrome Treatment Industry Dynamic
2.3.1 Hunter Syndrome Treatment Market Trends
2.3.2 Hunter Syndrome Treatment Market Drivers
2.3.3 Hunter Syndrome Treatment Market Challenges
2.3.4 Hunter Syndrome Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hunter Syndrome Treatment Players by Revenue
3.1.1 Global Top Hunter Syndrome Treatment Players by Revenue (2016-2021)
3.1.2 Global Hunter Syndrome Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hunter Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hunter Syndrome Treatment Revenue
3.4 Global Hunter Syndrome Treatment Market Concentration Ratio
3.4.1 Global Hunter Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hunter Syndrome Treatment Revenue in 2020
3.5 Hunter Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Hunter Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Hunter Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hunter Syndrome Treatment Breakdown Data by Type
4.1 Global Hunter Syndrome Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hunter Syndrome Treatment Forecasted Market Size by Type (2022-2027)

5 Hunter Syndrome Treatment Breakdown Data by Application
5.1 Global Hunter Syndrome Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hunter Syndrome Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hunter Syndrome Treatment Market Size (2016-2027)
6.2 North America Hunter Syndrome Treatment Market Size by Type
6.2.1 North America Hunter Syndrome Treatment Market Size by Type (2016-2021)
6.2.2 North America Hunter Syndrome Treatment Market Size by Type (2022-2027)
6.2.3 North America Hunter Syndrome Treatment Market Size by Type (2016-2027)
6.3 North America Hunter Syndrome Treatment Market Size by Application
6.3.1 North America Hunter Syndrome Treatment Market Size by Application (2016-2021)
6.3.2 North America Hunter Syndrome Treatment Market Size by Application (2022-2027)
6.3.3 North America Hunter Syndrome Treatment Market Size by Application (2016-2027)
6.4 North America Hunter Syndrome Treatment Market Size by Country
6.4.1 North America Hunter Syndrome Treatment Market Size by Country (2016-2021)
6.4.2 North America Hunter Syndrome Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hunter Syndrome Treatment Market Size (2016-2027)
7.2 Europe Hunter Syndrome Treatment Market Size by Type
7.2.1 Europe Hunter Syndrome Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hunter Syndrome Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hunter Syndrome Treatment Market Size by Type (2016-2027)
7.3 Europe Hunter Syndrome Treatment Market Size by Application
7.3.1 Europe Hunter Syndrome Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hunter Syndrome Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hunter Syndrome Treatment Market Size by Application (2016-2027)
7.4 Europe Hunter Syndrome Treatment Market Size by Country
7.4.1 Europe Hunter Syndrome Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hunter Syndrome Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hunter Syndrome Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hunter Syndrome Treatment Market Size by Type
8.2.1 Asia-Pacific Hunter Syndrome Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hunter Syndrome Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hunter Syndrome Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hunter Syndrome Treatment Market Size by Application
8.3.1 Asia-Pacific Hunter Syndrome Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hunter Syndrome Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hunter Syndrome Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hunter Syndrome Treatment Market Size by Region
8.4.1 Asia-Pacific Hunter Syndrome Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hunter Syndrome Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hunter Syndrome Treatment Market Size (2016-2027)
9.2 Latin America Hunter Syndrome Treatment Market Size by Type
9.2.1 Latin America Hunter Syndrome Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hunter Syndrome Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hunter Syndrome Treatment Market Size by Type (2016-2027)
9.3 Latin America Hunter Syndrome Treatment Market Size by Application
9.3.1 Latin America Hunter Syndrome Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hunter Syndrome Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hunter Syndrome Treatment Market Size by Application (2016-2027)
9.4 Latin America Hunter Syndrome Treatment Market Size by Country
9.4.1 Latin America Hunter Syndrome Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hunter Syndrome Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hunter Syndrome Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hunter Syndrome Treatment Market Size by Type
10.2.1 Middle East & Africa Hunter Syndrome Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hunter Syndrome Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hunter Syndrome Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hunter Syndrome Treatment Market Size by Application
10.3.1 Middle East & Africa Hunter Syndrome Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hunter Syndrome Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hunter Syndrome Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hunter Syndrome Treatment Market Size by Country
10.4.1 Middle East & Africa Hunter Syndrome Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hunter Syndrome Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Hunter Syndrome Treatment Introduction
11.1.4 Takeda Revenue in Hunter Syndrome Treatment Business (2016-2021)
11.1.5 Takeda Recent Development
11.2 GC Pharma.
11.2.1 GC Pharma. Company Details
11.2.2 GC Pharma. Business Overview
11.2.3 GC Pharma. Hunter Syndrome Treatment Introduction
11.2.4 GC Pharma. Revenue in Hunter Syndrome Treatment Business (2016-2021)
11.2.5 GC Pharma. Recent Development
11.3 JCR Pharmaceuticals Co Ltd.
11.3.1 JCR Pharmaceuticals Co Ltd. Company Details
11.3.2 JCR Pharmaceuticals Co Ltd. Business Overview
11.3.3 JCR Pharmaceuticals Co Ltd. Hunter Syndrome Treatment Introduction
11.3.4 JCR Pharmaceuticals Co Ltd. Revenue in Hunter Syndrome Treatment Business (2016-2021)
11.3.5 JCR Pharmaceuticals Co Ltd. Recent Development
11.4 RegenxBio Inc.
11.4.1 RegenxBio Inc. Company Details
11.4.2 RegenxBio Inc. Business Overview
11.4.3 RegenxBio Inc. Hunter Syndrome Treatment Introduction
11.4.4 RegenxBio Inc. Revenue in Hunter Syndrome Treatment Business (2016-2021)
11.4.5 RegenxBio Inc. Recent Development
11.5 Sangamo Therapeutics, Inc.
11.5.1 Sangamo Therapeutics, Inc. Company Details
11.5.2 Sangamo Therapeutics, Inc. Business Overview
11.5.3 Sangamo Therapeutics, Inc. Hunter Syndrome Treatment Introduction
11.5.4 Sangamo Therapeutics, Inc. Revenue in Hunter Syndrome Treatment Business (2016-2021)
11.5.5 Sangamo Therapeutics, Inc. Recent Development
11.6 ArmaGen Inc.
11.6.1 ArmaGen Inc. Company Details
11.6.2 ArmaGen Inc. Business Overview
11.6.3 ArmaGen Inc. Hunter Syndrome Treatment Introduction
11.6.4 ArmaGen Inc. Revenue in Hunter Syndrome Treatment Business (2016-2021)
11.6.5 ArmaGen Inc. Recent Development
11.7 Inventiva S.A.
11.7.1 Inventiva S.A. Company Details
11.7.2 Inventiva S.A. Business Overview
11.7.3 Inventiva S.A. Hunter Syndrome Treatment Introduction
11.7.4 Inventiva S.A. Revenue in Hunter Syndrome Treatment Business (2016-2021)
11.7.5 Inventiva S.A. Recent Development
11.8 Denali Therapeutics Inc.
11.8.1 Denali Therapeutics Inc. Company Details
11.8.2 Denali Therapeutics Inc. Business Overview
11.8.3 Denali Therapeutics Inc. Hunter Syndrome Treatment Introduction
11.8.4 Denali Therapeutics Inc. Revenue in Hunter Syndrome Treatment Business (2016-2021)
11.8.5 Denali Therapeutics Inc. Recent Development
11.9 Bioasis Technologies Inc.
11.9.1 Bioasis Technologies Inc. Company Details
11.9.2 Bioasis Technologies Inc. Business Overview
11.9.3 Bioasis Technologies Inc. Hunter Syndrome Treatment Introduction
11.9.4 Bioasis Technologies Inc. Revenue in Hunter Syndrome Treatment Business (2016-2021)
11.9.5 Bioasis Technologies Inc. Recent Development
11.10 Esteve
11.10.1 Esteve Company Details
11.10.2 Esteve Business Overview
11.10.3 Esteve Hunter Syndrome Treatment Introduction
11.10.4 Esteve Revenue in Hunter Syndrome Treatment Business (2016-2021)
11.10.5 Esteve Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hunter Syndrome Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Enzyme Replacement Therapy (ERT)
Table 3. Key Players of Hematopoietic Stem Cell Transplant (HSCT)
Table 4. Key Players of Others
Table 5. Global Hunter Syndrome Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hunter Syndrome Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hunter Syndrome Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Hunter Syndrome Treatment Market Share by Regions (2016-2021)
Table 9. Global Hunter Syndrome Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Hunter Syndrome Treatment Market Share by Regions (2022-2027)
Table 11. Hunter Syndrome Treatment Market Trends
Table 12. Hunter Syndrome Treatment Market Drivers
Table 13. Hunter Syndrome Treatment Market Challenges
Table 14. Hunter Syndrome Treatment Market Restraints
Table 15. Global Hunter Syndrome Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Hunter Syndrome Treatment Market Share by Players (2016-2021)
Table 17. Global Top Hunter Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hunter Syndrome Treatment as of 2020)
Table 18. Ranking of Global Top Hunter Syndrome Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Hunter Syndrome Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hunter Syndrome Treatment Product Solution and Service
Table 22. Date of Enter into Hunter Syndrome Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hunter Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Hunter Syndrome Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Hunter Syndrome Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Hunter Syndrome Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Hunter Syndrome Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Hunter Syndrome Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Hunter Syndrome Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Hunter Syndrome Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Hunter Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Hunter Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Hunter Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Hunter Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Hunter Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Hunter Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Hunter Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Hunter Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Hunter Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Hunter Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Hunter Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Hunter Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Hunter Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Hunter Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hunter Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hunter Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hunter Syndrome Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Hunter Syndrome Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Hunter Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Hunter Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Hunter Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Hunter Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Hunter Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Hunter Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Hunter Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Hunter Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hunter Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hunter Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hunter Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Hunter Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Takeda Company Details
Table 63. Takeda Business Overview
Table 64. Takeda Hunter Syndrome Treatment Product
Table 65. Takeda Revenue in Hunter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 66. Takeda Recent Development
Table 67. GC Pharma. Company Details
Table 68. GC Pharma. Business Overview
Table 69. GC Pharma. Hunter Syndrome Treatment Product
Table 70. GC Pharma. Revenue in Hunter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 71. GC Pharma. Recent Development
Table 72. JCR Pharmaceuticals Co Ltd. Company Details
Table 73. JCR Pharmaceuticals Co Ltd. Business Overview
Table 74. JCR Pharmaceuticals Co Ltd. Hunter Syndrome Treatment Product
Table 75. JCR Pharmaceuticals Co Ltd. Revenue in Hunter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 76. JCR Pharmaceuticals Co Ltd. Recent Development
Table 77. RegenxBio Inc. Company Details
Table 78. RegenxBio Inc. Business Overview
Table 79. RegenxBio Inc. Hunter Syndrome Treatment Product
Table 80. RegenxBio Inc. Revenue in Hunter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 81. RegenxBio Inc. Recent Development
Table 82. Sangamo Therapeutics, Inc. Company Details
Table 83. Sangamo Therapeutics, Inc. Business Overview
Table 84. Sangamo Therapeutics, Inc. Hunter Syndrome Treatment Product
Table 85. Sangamo Therapeutics, Inc. Revenue in Hunter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 86. Sangamo Therapeutics, Inc. Recent Development
Table 87. ArmaGen Inc. Company Details
Table 88. ArmaGen Inc. Business Overview
Table 89. ArmaGen Inc. Hunter Syndrome Treatment Product
Table 90. ArmaGen Inc. Revenue in Hunter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 91. ArmaGen Inc. Recent Development
Table 92. Inventiva S.A. Company Details
Table 93. Inventiva S.A. Business Overview
Table 94. Inventiva S.A. Hunter Syndrome Treatment Product
Table 95. Inventiva S.A. Revenue in Hunter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 96. Inventiva S.A. Recent Development
Table 97. Denali Therapeutics Inc. Company Details
Table 98. Denali Therapeutics Inc. Business Overview
Table 99. Denali Therapeutics Inc. Revenue in Hunter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 100. Denali Therapeutics Inc. Recent Development
Table 101. Bioasis Technologies Inc. Company Details
Table 102. Bioasis Technologies Inc. Business Overview
Table 103. Bioasis Technologies Inc. Hunter Syndrome Treatment Product
Table 104. Bioasis Technologies Inc. Revenue in Hunter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 105. Bioasis Technologies Inc. Recent Development
Table 106. Esteve Company Details
Table 107. Esteve Business Overview
Table 108. Esteve Hunter Syndrome Treatment Product
Table 109. Esteve Revenue in Hunter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 110. Esteve Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hunter Syndrome Treatment Market Share by Type: 2020 VS 2027
Figure 2. Enzyme Replacement Therapy (ERT) Features
Figure 3. Hematopoietic Stem Cell Transplant (HSCT) Features
Figure 4. Others Features
Figure 5. Global Hunter Syndrome Treatment Market Share by Application: 2020 VS 2027
Figure 6. Life Science Companies Case Studies
Figure 7. Research Institutes Case Studies
Figure 8. Hospital Case Studies
Figure 9. Hunter Syndrome Treatment Report Years Considered
Figure 10. Global Hunter Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Hunter Syndrome Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hunter Syndrome Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Hunter Syndrome Treatment Market Share by Regions (2022-2027)
Figure 14. Global Hunter Syndrome Treatment Market Share by Players in 2020
Figure 15. Global Top Hunter Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hunter Syndrome Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Hunter Syndrome Treatment Revenue in 2020
Figure 17. Global Hunter Syndrome Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Hunter Syndrome Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Hunter Syndrome Treatment Market Share by Type (2016-2027)
Figure 21. North America Hunter Syndrome Treatment Market Share by Application (2016-2027)
Figure 22. North America Hunter Syndrome Treatment Market Share by Country (2016-2027)
Figure 23. United States Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hunter Syndrome Treatment Market Share by Type (2016-2027)
Figure 27. Europe Hunter Syndrome Treatment Market Share by Application (2016-2027)
Figure 28. Europe Hunter Syndrome Treatment Market Share by Country (2016-2027)
Figure 29. Germany Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hunter Syndrome Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Hunter Syndrome Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Hunter Syndrome Treatment Market Share by Region (2016-2027)
Figure 39. China Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hunter Syndrome Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Hunter Syndrome Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Hunter Syndrome Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hunter Syndrome Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Hunter Syndrome Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Hunter Syndrome Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Hunter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Takeda Revenue Growth Rate in Hunter Syndrome Treatment Business (2016-2021)
Figure 59. GC Pharma. Revenue Growth Rate in Hunter Syndrome Treatment Business (2016-2021)
Figure 60. JCR Pharmaceuticals Co Ltd. Revenue Growth Rate in Hunter Syndrome Treatment Business (2016-2021)
Figure 61. RegenxBio Inc. Revenue Growth Rate in Hunter Syndrome Treatment Business (2016-2021)
Figure 62. Sangamo Therapeutics, Inc. Revenue Growth Rate in Hunter Syndrome Treatment Business (2016-2021)
Figure 63. ArmaGen Inc. Revenue Growth Rate in Hunter Syndrome Treatment Business (2016-2021)
Figure 64. Inventiva S.A. Revenue Growth Rate in Hunter Syndrome Treatment Business (2016-2021)
Figure 65. Denali Therapeutics Inc. Revenue Growth Rate in Hunter Syndrome Treatment Business (2016-2021)
Figure 66. Bioasis Technologies Inc. Revenue Growth Rate in Hunter Syndrome Treatment Business (2016-2021)
Figure 67. Esteve Revenue Growth Rate in Hunter Syndrome Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年）

Global Lennox-Gastaut Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4422 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、レノックス・ガストー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非外科的治療、外科的治療）、用途別市場規模（発作、眼球異常、脳波所見、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のダンピング症候群治療市場規模・現状・予測（2021年-2027年）

Global Dumping Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4163 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ダンピング症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療、外科療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のグッドパスチャー症候群治療市場規模・現状・予測（2021年-2027年）

Global Goodpasture Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5758 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、グッドパスチャー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、免疫抑制剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のレット症候群治療市場規模・現状・予測（2021年-2027年）

Global Rett Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5994 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、レット症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗てんかん薬、抗てんかん薬、鎮静催眠薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

Global HIV Associated Lipodystrophy Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4315 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、HIV関連リポジストロフィー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（特定薬剤治療、化粧品矯正治療）、用途別市場規模（病院、専門医クリニック、その他）、主要地域別市場規模（北米、アメリ...

世界のQT延長症候群治療市場規模・現状・予測（2021年-2027年）

Global Long QT Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4438 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、QT延長症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療、外科治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のアルポート症候群治療市場規模・現状・予測（2021年-2027年）

Global Alport Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5573 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、アルポート症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アンジオテンシン変換酵素（ACE）阻害剤、アンジオテンシン受容体遮断薬（ARB）、利尿剤、その他）、用途別市場規模（病院、診療所、そ...

世界のダンディーウォーカー症候群治療市場規模・現状・予測（2021年-2027年）

Global Dandy-Walker Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5138 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、ダンディーウォーカー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（頭蓋骨における外科移植用シャント、複数治療法）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、...

世界のアイゼンメンジャー症候群治療市場規模・現状・予測（2021年-2027年）

Global Eisenmenger Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5158 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、アイゼンメンジャー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗不整脈薬、抗凝血剤、エンドセリン受容体拮抗薬、その他）、用途別市場規模（血液検査、心電図（ECG）、胸部X線、心エコー検査...

造血幹細胞移植（HSCT）のグローバル市場調査 2019年 The global Hematopoietic Stem Cell Transplantation (HSCT) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hematopoietic Stem Cell Transplantation (HSCT) volume and value at global level, regional le…
世界のレット症候群治療市場規模・現状・予測（2021年-2027年） Rett Syndrome is a non-neurological degenerative disease that seriously affects children's psychomotor development. Market Analysis and Insights: Global Rett Syndrome Treatment Market The global Rett Syndrome Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in …
世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年） Hepatorenal syndrome (often abbreviated HRS) is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure. HRS is usually fatal unless a liver transplant is performed, although various treatments, such as dia…
世界のダンピング症候群治療市場規模・現状・予測（2021年-2027年） Dumping syndrome is a condition which develops after the surgery done to lose weight by removing all or part of the stomach. It is also called rapid gastric emptying and dumping syndrome, occurs when food especially sugar moves from the stomach into the small bowel too quickly. In some cases dumping…
世界のアルポート症候群治療市場規模・現状・予測（2021年-2027年） Alport Syndrome is the hereditary genetic disorder characterized by glomerulonephritis, abnormal vision, acute hearing loss and end-stage renal disease. Alport Syndrome is also called the hereditary nephritis. Market Analysis and Insights: Global Alport Syndrome Treatment Market The global Alport Sy…